Berjino, Rhia Joy V.

HRN: 24-87-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2024
CEFUROXIME 750MG (VIAL)
04/13/2024
04/20/2024
IV
400 MG
EVERY 8 HOURS
EMPIRIC
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: